Live Chat ×
Skip to main content

Interstitial Lung Disease



Evaluated by: 
David B. Kaminsky, MD, FIAC, October 24, 2018
Original release date: December 12, 2018
Access to this course expires on:  October 24, 2021
CME/SAM 3.25

Faculty:
Part 1: Marie-Christine Aubry, MD
Part 2: Marie-Christine Aubry, MD & Paul J. Kurtin, MD

Learning Objectives:
  • Identify the key histologic diagnostic features that allows for the distinction of neoplastic and non-neoplastic diseases with prominent lymphohistiocytic infiltrate
  • Discern relevant clinical and radiologic information and ancillary studies that assists with formulating a diagnosis
  • Understand the prognostic and therapeutic implications of the various diagnosis of neoplastic and non-neoplastic diseases with prominent lymphohistiocytic infiltrate